MET Exon 14 (Splice Site)
About
Gene context: MET
Biomarker Type: Somatic Variant
Present: True
Chromosome: 7
Variant Annotation: Splice Site
Exon: 14
Requires Oncogenic: True
Legacy biomarker representation, assumes GRCh37 / hg19 genome build.
Mappings
Therapeutic response
Precision oncology relationships for therapeutic response involving this biomarker.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Capmatinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Capmatinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib |